Abstract:BACKGROUND: Previous studies have suggested that melatonin may produce antinociception through peripheral and central mechanisms. Based on the preliminary encouraging results of studies of the effects of melatonin on pain modulation, the important question has been raised of whether there is a dose relationship in humans of melatonin on pain modulation.OBJECTIVE: The objective was to evaluate the analgesic dose response of the effects of melatonin on pressure and heat pain threshold and tolerance and the sedative effects.METHODS: Sixty-one healthy subjects aged 19 to 47 y were randomized into one of four groups: placebo, 0.05 mg/kg sublingual melatonin, 0.15 mg/kg sublingual melatonin or 0.25 mg/kg sublingual melatonin. We determine the pressure pain threshold (PPT) and the pressure pain tolerance (PPTo). Quantitative sensory testing (QST) was used to measure the heat pain threshold (HPT) and the heat pain tolerance (HPTo). Sedation was assessed with a visual analogue scale and bispectral analysis.RESULTS: Serum plasma melatonin levels were directly proportional to the melatonin doses given to each subject. We observed a significant effect associated with dose group. Post hoc analysis indicated significant differences between the placebo vs. the intermediate (0.15 mg/kg) and the highest (0.25 mg/kg) melatonin doses for all pain threshold and sedation level tests. A linear regression model indicated a significant association between the serum melatonin concentrations and changes in pain threshold and pain tolerance (R(2) = 0.492 for HPT, R(2) = 0.538 for PPT, R(2) = 0.558 for HPTo and R(2) = 0.584 for PPTo).CONCLUSIONS: The present data indicate that sublingual melatonin exerts well-defined dose-dependent antinociceptive activity. There is a correlation between the plasma melatonin drug concentration and acute changes in the pain threshold. These results provide additional support for the investigation of melatonin as an analgesic agent. Brazilian Clinical Trials Registry (ReBec): (U1111-1123-5109). IRB: Research Ethics Committee at the Hospital de Clínicas de Porto Alegre.

Selective Mt2 Melatonin Receptor Antagonist Blocks Melatonin-Induced Antinociception in Rats

The Analgesic Effects of Peripheral and Central Administration of Melatonin in Rats.

Melatonin Suppresses Neuropathic Pain Via MT2-Dependent and -Independent Pathways in Dorsal Root Ganglia Neurons of Mice.

Antinociceptive Effects of Novel Melatonin Receptor Agonists in Mouse Models of Abdominal Pain

Effects of Melatonin on Orphanin FQ/nociceptin-induced Hyperalgesia in Mice

Melatonin Induces Analgesic Effects through MT2 Receptor-Mediated Neuroimmune Modulation in the Mice Anterior Cingulate Cortex

Melatonin Enhances Antinociceptive Effects of Δ-, but Not Μ-Opioid Agonist in Mice

Melatonin Inhibits the Up-Regulation of N-type Calcium Channel in Neuropathic Pain by Activating the MT2 Receptor in Rats

[Effect of Melatonin on Release of Beta-Endorphin, Norepinephrine and 5-Hydroxytryptamine in Rat Brain].

Melatonin Attenuates the Development of Antinociceptive Tolerance to Delta-, but Not to Mu-Opioid Receptor Agonist in Mice

Melatonin attenuated chronic visceral pain by reducing Nav1.8 expression and nociceptive neuronal sensitization

A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats.

The anti-inflammatory and analgesic effects of intraperitoneal melatonin after spinal nerve ligation are mediated by inhibition of the NF-κB/NLRP3 inflammasome signaling pathway

Analgesic Effects of Melatonin on Post-Herpetic Neuralgia.

The anti-inflammatory and analgesic effects of intraperitoneal melatonin after spinal nerve ligation are mediated by inhibition of the NF-B/NLRP3 inflammasome signaling pathway

Effects of Intrathecal Injections of Melatonin Analogs on Capsaicin-Induced Secondary Mechanical Allodynia and Hyperalgesia in Rats

A Phase II, Randomized, Double-Blind, Placebo Controlled, Dose-Response Trial of the Melatonin Effect on the Pain Threshold of Healthy Subjects

Melatonin‐mediated Inhibition of Cav3.2 T‐type Ca2+ Channels Induces Sensory Neuronal Hypoexcitability Through the Novel Protein Kinase C‐eta Isoform

Exogenous melatonin in the treatment of pain: a systematic review and meta-analysis.

Exogenous Melatonin in the Treatment of Pain: a Systematic Review and Meta-Analysis

Melatonin Improves Mitochondrial Dysfunction and Attenuates Neuropathic Pain by Regulating SIRT1 in Dorsal Root Ganglions